| Comment Number: | 522418-07377 |
| Received: | 7/10/2006 5:16:31 PM |
| Organization: | University of St. Thomas |
| Commenter: | Michael Bellamy |
| State: | MN |
| Subject: | Business Opportunity Rule |
| Title: | Notice of Proposed Rulemaking |
| CFR Citation: | 16 CFR Part 437 |
| No Attachments |
Comments:
My wife and I have been using Xango for some time. We are convinced that it has been beneficial for both of our cancers, not to mention inflamation and general-all-around-health. Any more red tape involved in ordering the product, or similar mail-order products, would be extremely counter-productive. I should mention that we are both believers in traditional and non-traditional (as defined in the West) modes of medicine. We just happen to believe that xango is one of the most effective medicines we can take out of all the available alternatives. There is plenty of red-tape involved already in the process of ordering the product. Please consider the deleterious effect of still more formal procedures for those who wish to order the product. There have been no indications of fraud in our experience so far. When it comes to fraud, I suspect that some of the practices of the traditional drug companies might be a better place to look. I write this from Canada, where drug prices are regulated by the government and where, as I assume you know, American drug companies have tried to prevent access to American markets. We have had occasion, incidentally, to take prescription drugs in Canada. So far, neither one of us has suffered any consequences as a result of sloppy procedures or quack medicine. In fact, when it comes to scrupulous regulatory practices, believe me, nobody can top the Canadians. Thank you for your consideration... Michael and Mary-Anne Bellamy